Kara E. Williams

Kara E. Williams serves as a Contract Specialist at the Naval Medical Logistics Command (N62645), where she plays a pivotal role in executing mission-critical acquisitions that sustain the readiness of U.S. Navy and Marine Corps medical forces. She manages the full lifecycle of procurement actions for high-priority medical equipment, diagnostic tools, and life-sustaining pharmaceuticals, ensuring compliance with FAR and DOD acquisition regulations. Her work directly supports the command’s strategic objective of maintaining a responsive, global medical logistics pipeline for combat casualty care and advanced clinical operations, with a focus on point-of-care diagnostics and modernized medical systems. Williams cultivates partnerships with a diverse range of vendors, primarily in the medical manufacturing and healthcare services sectors. While no single contractor dominates her portfolio, she routinely engages with firms specializing in surgical instrumentation, analytical laboratory equipment, and pharmaceutical preparation, fostering relationships grounded in performance accountability and regulatory compliance. Her contracting approach emphasizes technical evaluation, risk mitigation, and supplier reliability to ensure mission continuity across austere and deployed environments. Her procurement patterns reflect a strong preference for open competition, with 92.6% of her acquisitions conducted without set-aside restrictions, aligning with the Navy’s need for rapid, scalable solutions. The remaining 7.4% are awarded as total small business set-asides under FAR 19.5, demonstrating a measured but intentional commitment to small business participation without compromising operational urgency or technical requirements. Williams’ primary NAICS focus lies in surgical and medical instrument manufacturing (339112) and general medical and surgical hospitals (622110), reflecting her expertise in procuring complex medical devices, diagnostic platforms, and associated clinical support services. She also regularly acquires ophthalmic goods and analytical laboratory instruments, showcasing a deep technical understanding of medical device standards, FDA regulatory frameworks, and the interoperability demands of forward-deployed medical systems.